Hostname: page-component-7f64f4797f-9t7q9 Total loading time: 0 Render date: 2025-11-11T09:11:23.620Z Has data issue: false hasContentIssue false
  • English
  • Français

Toxoplasma gondii

Published online by Cambridge University Press:  21 June 2016

Deborah J. Zygmunt
Deborah J. Zygmunt*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee
*
Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.2561
Get access Rights & Permissions [Opens in a new window]

Extract

Toxoplasma gondii is an obligate intracellular parasite that is a worldwide cause of infections in virtually all mammalian species, including humans. Although toxoplasmosis is extremely common in humans, most cases are subclinical and are revealed only by the presence of antibodies to this parasite. Prior to the use of immunosuppresive therapy and the recognition of the acquired immune deficiency syndrome (AIDS), the most devastating consequence of toxoplasmosis was seen in children of women who acquired acute toxoplasmosis in their first trimester of pregnancy.

In the past two decades, this pathogen has become increasingly recognized in immunocompromised patients as a common cause of encephalitis. The tragedy of toxoplasmosis is that it is a preventable disease. French investigators, have clearly defined the risk and range of severity of congenital toxoplasmosis, the value of systemic screening and patient education, and the value of treatment of the mother during pregnancy to prevent transmission to the fetus. Prevention of a large portion of cerebral toxoplasmosis cases in immunocompromised patients might be possible if congenital toxoplasmosis was better controlled in the United States. The first step in controlling toxoplasmosis in the United States is a better appreciation of this infection.

Information

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 4 , April 1990 , pp. 207 - 213
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Desmonts, G, Couvreur, J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Medr 1974;290:1110–1116.Google Scholar
2. Luft, BJ, Remington, JS. Toxoplasmic encephalitis. J Infect Dis. 1988;157:1–6.Google Scholar
3. McCabe, R, Remington, JS. Toxoplasmosis: the time has come. N Engl J Med. 1988;318:313–315.Google Scholar
4. Desmonts, G, Dafffos, F, Forestier, F, Capella-Pavlovsky, M, Thulliez, P, Chartier, M. Prenatal diagnosis of congenital toxoplasmosis. Lancet. 1985;1:500–504.Google Scholar
5. Daffos, F, Forestier, F, Capella-Pavlovsky, M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 1988;318:271–275.Google Scholar
6. Feldman, HA. Toxoplasmosis. N Engl J Med. 1968;279:1370–1375.Google Scholar
7. Krick, JA, Remington, JS. Toxoplasmosis in the adult—an overview. N Engl J Med. 1978;298:550–553.Google Scholar
8. Teutsch, SM, Juranek, DD, Sulzer, A, Dubey, JP, Sikes, RK. Epidemic toxoplasmosis associated with infected cats. N Engt J Med. 1979;300:695–699.Google Scholar
9. Dorfman, RF, Remington, JS. Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med. 1973;289:878–881.Google Scholar
10. Ruskin, J, Remington, JS. Toxoplasmosis in the compromised host. Ann Intern Med. 1976;84:193–199.Google Scholar
11. Vietzke, WM, Gelderman, AH, Grimley, PM, Valsamis, MP. Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute. Cancer. 1968;21:816–827.Google Scholar
12. Lakhanpal, V, Schocket, SS, Nirankari, VS. Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am J Ophthalmol. 1983;95:605–613.Google Scholar
13. Holliman, RE, Fleck, DG. Toxoplasma infection in the elderly. Geriatr Med Today. 1986:5:97–102.Google Scholar
14. Nathan, CR, Murray, HW, Cohn, ZA. Current concepts: the macrophage as an effector cell. N Engl J Med. 1980;303:622–626.Google Scholar
15. Rynmg, FW, McLeod, R, Maddox, JC, Hunt, S, Remington, JS. Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med. 1979;90:47–49.Google Scholar
16. Luft, BJ, Brooks, RG, Conley, FK, McCabe, RE, Remington, JS. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA. 1984;252:913–917.Google Scholar
17. Navia, BA, Petitol, CK, Gold, JWM, Cho, E-S, Jordan, BD, Pnce, RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986;19:224–238.Google Scholar
18. Post, MJD, Kursunoglu, SJ, Hensley, GT, Chan, JC, Moskowitz, LB, Hoffman, TA. Cranial CT in acquired immunodeficiency syndrome: spectrum of disease and optimal contrast enhancement technique. Am J Radiol. 1985;145:929–940.Google Scholar
19. Elkin, CM, Leon, E, Grenell, SL, Leeds, NE. Intracranial lesions in the acquired immunodeficiency syndrome: radiological (computed to-mographic) features. JAMA. 1985;253:393–396.Google Scholar
20. Levy, RM, Bredesen, DE, Rosenblum, ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985;62:457–495.Google Scholar
21. Moskowitz, LB, Hensley, GT, Chan, JC, Conley, FK, Post, MJD. Brain biopsies in patients with acquited immune deficiency syndrome. Arch Pathol Lab Med. 1984;108:368–371.Google Scholar
22. Sun, T, Greenspan, J, Tenenbaum, M, et al. Diagnosis of cerebral toxoplasmosis using fluorescein-labeled antitoxoplasma monoclonal antibodies. Am J Surg Pathol. 1986;10:312–316.Google Scholar
23. Conley, FK, Jenkins, KA, Remington, JS. Toxoplasma gondii infection of the central nervous system: use of the peroxidase-antiperoxidase method to demonstrate Toxoplasma in formalin fixed, paraffin embedded tissue sections. Hum Pathol. 1981;12:690–698.Google Scholar
24. Lindenschmidt, EG. Enzyme-linked immunosorbent assay for detection of soluble Toxoplasma gondii antigen in acute-phase toxoplasmosis. Eur J Clin Microbiol. 1985;4:488–492.Google Scholar